Hydroxyapatite deposition disease (HADD) at an unspecified anatomical site — calcium hydroxyapatite crystals deposited in or around a joint without documentation of which joint is affected.
Verified May 8, 2026 · 4 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 8
- Region
- General
Documentation tips
What should appear in the chart to support M11.00.
Source · Editorial brief grounded in 4 cited references ↓
- Document the specific joint by name (e.g., right shoulder, left hip) at every encounter — this unlocks a site-specific M11.0x code and avoids the unspecified fallback.
- Record imaging findings that confirm hydroxyapatite deposits: X-ray, ultrasound, or MRI findings noting calcific tendinitis or periarticular calcification, including size and location of deposits.
- Note whether the presentation is acute (inflammatory flare with warmth, swelling, severe pain) or chronic/recurrent, as this affects medical necessity narratives for procedures.
- If multiple joints are involved, document each joint separately so individual site-specific codes can be assigned rather than defaulting to M11.00.
- Distinguish HADD from chondrocalcinosis (M11.2x, CPPD) and gout (M10.x) in the clinical impression — crystal type drives code selection, not just the term 'crystal arthropathy.'
Related CPT procedures
Procedure codes commonly billed with M11.00. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M11.00 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Using M11.00 when the affected joint is documented but the coder defaults to unspecified — always check the note for joint name and laterality before selecting this code.
- Confusing HADD (M11.0x) with chondrocalcinosis/CPPD (M11.2x) or gout (M10.x); these are distinct crystal types and distinct code families — do not interchange them based on a generic 'crystal arthropathy' label.
- Assigning M11.00 on a claim for a site-specific procedure (e.g., 23415 shoulder release) — the unspecified-site code creates a laterality mismatch that triggers medical necessity denials.
- Billing M11.00 for calcific tendinitis of the shoulder without querying whether the provider's intended diagnosis is HADD — calcific tendinitis of the shoulder has its own codes (M75.3x) and the distinction matters for accurate coding.
Clinical context
Source · Editorial summary grounded in 4 cited references ↓
M11.00 is the fallback code for hydroxyapatite deposition disease when the treating provider has not documented which joint or body region is involved. HADD is a crystal arthropathy in which calcium hydroxyapatite deposits form in periarticular soft tissues, tendons, or within a joint itself, triggering acute or chronic inflammatory pain. The shoulder (rotator cuff) is the most commonly affected site, but deposits can occur at the hip, elbow, wrist, knee, ankle, or foot.
Use M11.00 only when site is genuinely undocumented or when a multi-site presentation has not been individually specified. If the provider documents a specific joint — even unilaterally — move to the appropriate site-specific code under M11.01–M11.09. For bilateral involvement at an identified joint, the site-specific bilateral synonym code applies; do not default to M11.00 simply because two sides are affected.
M11.00 groups to MS-DRG 553 (Bone Diseases and Arthropathies with MCC) or 554 (without MCC) based on complication/comorbidity status. Because the unspecified-site code carries inherent specificity risk, expect payer scrutiny if it appears on claims for site-specific procedures such as ultrasound-guided needling or shoulder arthroscopy.
Sibling codes
Other billable codes under M11.0 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 4 cited references ↓
01When is M11.00 the correct code rather than a site-specific M11.0x code?
02Is M11.00 the right code for calcific tendinitis of the shoulder?
03How does M11.00 differ from M11.20 (chondrocalcinosis, unspecified site)?
04Which MS-DRGs does M11.00 map to?
05Can M11.00 be reported with a procedure code for joint injection or aspiration?
06Does M11.00 require a 7th character extension?
07Can M11.00 be used as a primary diagnosis for an E/M visit?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective Oct 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M05-M14/M11-/M11.00
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M11.00
- 04icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M05-M14/M11-/M11.011
Mira AI Scribe
The Mira AI Scribe captures joint name, laterality, and crystal type from the encounter note, along with imaging confirmation of hydroxyapatite deposits (X-ray calcification, ultrasound echogenic foci, or MRI signal). This prevents a drop to M11.00 when a site-specific code is supported — avoiding medical necessity mismatches on procedure claims and downstream payer queries.
See how Mira captures M11.00 documentation